NYSE:BHVNBiotechs
Biohaven (BHVN) Narrows Loss and Adds Shelf Registration Is Its Capital Strategy Evolving?
Biohaven Ltd. reported first-quarter 2026 results in the past, narrowing its net loss to US$130.53 million from US$221.68 million a year earlier, while loss per share from continuing operations declined to US$0.88 from US$2.17.
On the same day, Biohaven filed an omnibus shelf registration covering a wide range of securities, potentially giving the company considerable flexibility in how it may access capital in the future.
With these earnings and the broad shelf registration in mind, we’ll...